Literature DB >> 10220313

Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties.

A Parikh1, P D Josephy, F P Guengerich.   

Abstract

Random mutagenesis is an approach that has the potential to provide useful information about cytochrome P450 (P450) enzymes but has not been extensively used to date. We applied our previously developed systems for generation of random libraries of human P450 1A2 with the putative substrate recognition sequences mutated (individual residues) and an Escherichia coli genotoxity assay involving reversion to lac prototrophy as a response to activation of the heterocyclic amine 2-amino-3,5-dimethylimidazo[4,5-f]quinoline (MeIQ). A total of 27 mutants were screened from 6000 clones, a small portion of the library. The sequence changes were identified, and E. coli membranes containing each P450 (with NADPH-P450 reductase expressed using a bicistronic vector) were used to determine kcat and Km values for 7-ethoxyresorufin and phenacetin O-deethylation and the (in vitro) activation of MeIQ with another bacterial genotoxicity system (Salmonella typhimurium umu). Within each assay, the values of kcat/Km varied by 2 orders of magnitude, and in some cases these parameters were 3-4-fold higher than for the native enzyme. The profiles of the mutants varied considerably for the three different reactions. Some of the mutants in the Asp-320 region may be compared with site-directed mutants of rat P450 1A2 already reported, with several differences noted. Other mutants have not been studied before in human P450 1A2 or homologues and are of interest; i.e., all Phe-226 mutants showed considerably reduced activity but Glu-225 mutants had increased catalytic activities. In principle, this approach may be applied to random mutagenesis of any enzyme that converts chemicals to mutagens and can be expressed in bacteria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220313     DOI: 10.1021/bi990142+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 2.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

3.  Significant increase in phenacetin oxidation on L382V substitution in human cytochrome P450 1A2.

Authors:  Qingbiao Huang; Grazyna D Szklarz
Journal:  Drug Metab Dispos       Date:  2010-03-24       Impact factor: 3.922

4.  Re-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamide.

Authors:  Ling Sun; Chong S Chen; David J Waxman; Hong Liu; James R Halpert; Santosh Kumar
Journal:  Arch Biochem Biophys       Date:  2007-01-08       Impact factor: 4.013

Review 5.  Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications.

Authors:  Zhong Li; Yuanyuan Jiang; F Peter Guengerich; Li Ma; Shengying Li; Wei Zhang
Journal:  J Biol Chem       Date:  2019-12-06       Impact factor: 5.157

6.  Structural features of cytochrome P450 1A associated with the absence of EROD activity in liver of the loricariid catfish Pterygoplichthys sp.

Authors:  Thiago E M Parente; Mauro F Rebelo; Manuela L da-Silva; Bruce R Woodin; Jared V Goldstone; Paulo M Bisch; Francisco J R Paumgartten; John J Stegeman
Journal:  Gene       Date:  2011-08-05       Impact factor: 3.688

7.  Arginine to lysine 108 substitution in recombinant CYP1A2 abolishes methoxyresorufin metabolism in lymphoblastoid cells.

Authors:  Nicholas E Hadjokas; Renke Dai; Fred K Friedman; Michael J Spence; Barry J Cusack; Robert E Vestal; Yongsheng Ma
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 8.  Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.

Authors:  Shu-Feng Zhou; Li-Ping Yang; Zhi-Wei Zhou; Ya-He Liu; Eli Chan
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

9.  Identification of amino acid residues involved in 4-chloroindole 3-hydroxylation by cytochrome P450 2A6 using screening of random libraries.

Authors:  Zhi-Gang Zhang; Yan Liu; F Peter Guengerich; Johannes H Matse; Jun Chen; Zhong-Liu Wu
Journal:  J Biotechnol       Date:  2008-10-15       Impact factor: 3.307

10.  Analysis of Cytochrome P450 Conserved Sequence Motifs between Helices E and H: Prediction of Critical Motifs and Residues in Enzyme Functions.

Authors:  Numan Oezguen; Santosh Kumar
Journal:  J Drug Metab Toxicol       Date:  2011-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.